How would you approach treating a patient with active rheumatoid arthritis and a history of treated lymphoma that is currently in remission?
Given the controversy in the literature regarding TNFi or MTX associated lymphoma in patients with RA.
Answer from: at Academic Institution
I would individualize treatment in each patient depending on degree of RA activity, type of lymphoma and length of time of remission with shared decision-making between myself, patient and oncologist. For moderate to high degree of activity of RA, in general, rituximab in keeping with the ACR 2021 g...